/ Press Releases

LOS ANGELES, CA / December 5, 2016 / Vitality Biopharma, Inc. (OTCQB: VBIO) (“Vitality” or the “Company”), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, announced today that it will be presenting at the 9th Annual LD Micro Main Event on Thursday, December 8th at 8 AM PST / 11 AM EST at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Robert Brooke, CEO of Vitality Biopharma will be presenting, as well as meeting with investors.

The LD Micro Main Event is the largest independent conference for small/microcap companies and will feature 240 presenting names.

View Vitality Biopharma’s profile here: http://www.ldmicro.com/profile/vbio

News Compliments of Accesswire.

About Vitality Biopharma (OTCQB: VBIO)

Vitality Biopharma is dedicated to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. For more information, visit: www.vitality.bio. Follow us on Facebook, Twitter, and LinkedIn.

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event).

In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and microcap universe.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com/events for more information.

Contact:

Vitality Biopharma
Investor Relations
info@vitality.bio
1-530-231-7800
www.vitality.bio